Skip to main content
ImmuneCited

Omega-3 Fatty Acids (EPA/DHA) لـ Autoimmune Conditions

B

The VITAL trial showed a 15% reduction in autoimmune disease risk with omega-3 supplementation. Additional clinical trials demonstrate benefits for supporting balanced inflammatory responses in rheumatoid arthritis and inflammatory bowel disease.

<\/script>\n
`; }, get iframeSnippet() { const domain = 'immunecited.com'; const params = 'ingredient\u003Domega\u002D3\u0026condition\u003Dautoimmune\u002Dconditions'; return ``; }, get activeSnippet() { return this.method === 'script' ? this.scriptSnippet : this.iframeSnippet; }, copySnippet() { navigator.clipboard.writeText(this.activeSnippet).then(() => { this.copied = true; setTimeout(() => { this.copied = false; }, 2000); }); } }" @keydown.escape.window="open = false" @click.outside="open = false">

Embed This Widget

Style



      
      
    

Widget powered by . Free, no account required.

B

الخلاصة

The VITAL trial showed a 15% reduction in autoimmune disease risk with omega-3 supplementation. Additional clinical trials demonstrate benefits for supporting balanced inflammatory responses in rheumatoid arthritis and inflammatory bowel disease.

Key Study Findings

Review
Impact of Nutritional Diet Therapy on Rheumatoid Arthritis Disease Activity.
Dose: None مقابل: None Outcome: rheumatoid arthritis disease activity modulation through diet التأثير: None None

المجتمع المدروس: patients with rheumatoid arthritis

Case Reports n=1
GPIHBP1 Autoantibody-Related Hypertriglyceridemia in a 12-Year-Old Girl With Systemic Lupus Erythematosus.
Dose: None مقابل: None Outcome: GPIHBP1 autoantibody and LPL mass normalization التأثير: None None

المجتمع المدروس: 12-year-old girl with SLE and severe hypertriglyceridemia

Review
Epigenetic and Mitochondrial Metabolic Dysfunction in Multiple Sclerosis: A Review of Herbal Drug Approaches and …
Dose: None مقابل: None Outcome: Epigenetic and mitochondrial modulation in MS التأثير: None None

المجتمع المدروس: Multiple sclerosis patients (review)

Review
The Role of Nutrition in the Development, Management, and Prevention of Rheumatoid Arthritis: A Comprehensive …
Dose: None مقابل: None Outcome: RA risk and disease activity التأثير: None None

المجتمع المدروس: Patients with rheumatoid arthritis

Review
Specialized pro-resolving mediators and autoimmunity: Recent insights and future perspectives.
Dose: None مقابل: None Outcome: None التأثير: None None

المجتمع المدروس: None

Systematic Review
Modulating inflammation and oxidative stress in rheumatoid arthritis: a systematic review of nutraceutical interventions.
Dose: None مقابل: None Outcome: None التأثير: None None

المجتمع المدروس: Systematic review of nutraceuticals in rheumatoid arthritis

Key Statistics

10

الدراسات

25000

المشاركون

Positive

B

التقييم

Referenced Papers

BMJ (Clinical research … 2022 9 اقتباسات
Nederlands tijdschrift voor … 2022 1 اقتباسات
Microbiology and immunology 2020 8 اقتباسات
Current diabetes reports 2010 33 اقتباسات
Journal of the … 2010 11 اقتباسات
Current opinion in … 2005 26 اقتباسات
Current atherosclerosis reports 2004 464 اقتباسات
Journal of the … 2002 2016 اقتباسات
Biochemical Society transactions 1995 15 اقتباسات
World review of … 1994 8 اقتباسات
The American journal … 1991 2278 اقتباسات
Rheumatic diseases clinics … 1991 19 اقتباسات

Dosage & Usage

mg = milligrams · mcg = micrograms (1,000× smaller) · IU = International Units

الجرعات الشائعة

general:
250-500 mg combined EPA/DHA/day
antiinflammatory:
1,000-3,000 mg combined EPA/DHA/day

الحد الأعلى: 3,000 mg/day EPA+DHA (FDA-recognized as safe)

الجرعات المدروسة في الأبحاث

الجرعة المدة التأثير ن
None -- Positive --
None -- Positive 1
None -- Positive --
None -- Positive --
None -- Mixed --
None -- Mixed --
None -- Positive --
None -- Neutral --

أفضل وقت للتناول: With meals

Safety & Side Effects

الآثار الجانبية المُبلّغ عنها

  • Fishy aftertaste and burping
  • Gastrointestinal discomfort (nausea, diarrhea)
  • Increased bleeding risk at high doses
  • Potential LDL cholesterol increase at very high doses

التفاعلات المعروفة

  • Anticoagulants and antiplatelet drugs (may increase bleeding risk)
  • Blood pressure medications (additive blood pressure lowering)
  • Orlistat (may reduce omega-3 absorption)
  • Cyclosporine (may modify immunosuppressive effects)

الحد الأقصى المسموح به: 3,000 mg/day EPA+DHA (FDA-recognized as safe)

استشر مقدم الرعاية الصحية دائماً قبل البدء بأي مكمل غذائي.

Frequently Asked Questions

Does Omega-3 Fatty Acids (EPA/DHA) help with Autoimmune Conditions?
Based on 10 studies with 25,000 participants, there is moderate evidence from clinical studies that Omega-3 Fatty Acids (EPA/DHA) may support Autoimmune Conditions management. Our evidence grade is B (Good Evidence).
How much Omega-3 Fatty Acids (EPA/DHA) should I take for Autoimmune Conditions?
Studies have used various dosages. A commonly studied range is 250-500 mg combined EPA/DHA/day. Always consult your healthcare provider before starting any supplement regimen.
Are there side effects of Omega-3 Fatty Acids (EPA/DHA)?
Reported side effects may include Fishy aftertaste and burping, Gastrointestinal discomfort (nausea, diarrhea), Increased bleeding risk at high doses, Potential LDL cholesterol increase at very high doses. Most side effects are mild and dose-dependent. Consult your doctor if you experience any adverse reactions.
How strong is the evidence for Omega-3 Fatty Acids (EPA/DHA) and Autoimmune Conditions?
We rate the evidence as Grade B (Good Evidence). This rating is based on 10 peer-reviewed studies with 25,000 total participants. The overall direction of effect is positive.

Related Evidence

مكونات أخرى لـ Autoimmune Conditions

Omega-3 Fatty Acids (EPA/DHA) لحالات أخرى

إخلاء مسؤولية FDA: لم تُقيَّم هذه البيانات من قبل إدارة الغذاء والدواء (FDA). لا تهدف المنتجات والمعلومات الواردة في هذا الموقع إلى تشخيص أو علاج أو شفاء أو الوقاية من أي مرض. تستند تقييمات الأدلة المعروضة إلى تحليلنا للأبحاث المحكّمة المنشورة ولا تُشكّل نصيحة طبية. استشر مقدم الرعاية الصحية دائماً قبل البدء بأي نظام مكملات.